{"product_id":"iba-worldwide-business-model-canvas","title":"IBA Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIBA's Business Model: Unveiling the Engine of Success\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eCurious about the engine driving IBA's success? Our Business Model Canvas lays bare the core components, from customer relationships to revenue streams. Discover the strategic brilliance that fuels their market position and gain inspiration for your own ventures.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospitals and Cancer Centers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIBA actively partners with premier hospitals and cancer centers worldwide to deploy and manage its advanced proton therapy systems. These collaborations are fundamental for advancing clinical research, providing cutting-edge patient care, and substantiating the effectiveness of novel radiation treatments.\u003c\/p\u003e\n\u003cp\u003eFor instance, IBA's strategic alliances with institutions such as Heidelberg University Hospital in Germany and Apollo Hospitals in India exemplify this commitment. These partnerships not only facilitate the adoption of proton therapy but also contribute vital data for ongoing studies, reinforcing the value proposition of IBA's technology in the oncology landscape.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch Institutions and Universities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIBA actively fosters strategic alliances with leading research institutions and universities worldwide. These partnerships are crucial for pushing the boundaries of particle accelerator technology and uncovering novel applications. For instance, in 2023, IBA announced a significant collaboration with a major European university to explore advanced proton therapy techniques, aiming to enhance treatment precision for complex cancers.\u003c\/p\u003e\n\u003cp\u003eThese collaborations are instrumental in driving innovation and providing the scientific validation necessary for IBA's cutting-edge solutions. They facilitate essential clinical trials, ensuring that new therapeutic approaches are rigorously tested and proven effective. Such joint development efforts are paving the way for future therapy modalities, potentially revolutionizing patient care.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnology and Component Suppliers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eIBA collaborates with specialized technology and component suppliers to secure essential parts and specialized knowledge for its intricate accelerator systems. These collaborations are vital for accessing state-of-the-art components and refining production methods.\u003c\/p\u003e\n\u003cp\u003eBy partnering with key suppliers, IBA ensures the consistent high quality and dependability of its advanced medical devices, thereby bolstering a resilient supply chain. For instance, in 2024, IBA continued to strengthen its relationships with providers of superconducting magnets and high-power radiofrequency components, critical for its proton therapy systems.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIndustrial Partners and Sterilization Service Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eIBA's industrial solutions segment thrives on strategic alliances with industrial clients and specialized sterilization service providers. These partnerships are crucial for deploying and maintaining IBA's advanced electron beam and X-ray sterilization technologies across diverse sectors like medical devices, food preservation, and semiconductor manufacturing.\u003c\/p\u003e\n\u003cp\u003eThese collaborations are designed to broaden IBA's footprint in industrial applications, ensuring efficient and effective sterilization solutions are accessible to a wider market. For instance, recent engagements with SteriLab and BENEBION highlight the practical application and expansion of these vital partnerships.\u003c\/p\u003e\n\u003cp\u003eKey aspects of these partnerships include:\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eInstallation and Maintenance:\u003c\/strong\u003e Collaborating on the setup and ongoing upkeep of electron beam and X-ray systems.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMarket Expansion:\u003c\/strong\u003e Leveraging partners' existing networks to reach new industrial clients and applications.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eService Provision:\u003c\/strong\u003e Working with sterilization service providers to offer specialized irradiation services to their customer base.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTechnology Adoption:\u003c\/strong\u003e Facilitating the integration of advanced sterilization methods into various industrial processes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRadiopharmaceutical Developers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eIBA collaborates with radiopharmaceutical developers to ensure a steady supply of critical medical isotopes, like Actinium-225. These partnerships are vital for overcoming supply constraints and broadening the use of IBA's accelerator technology in nuclear medicine.  A significant collaboration in this sector is the PanTera joint venture.\u003c\/p\u003e\n\u003cp\u003eThese alliances are crucial for advancing the nuclear medicine field. For instance, the demand for alpha-emitting isotopes like Actinium-225 is rapidly increasing, driven by new targeted alpha therapies. IBA's role in providing the necessary accelerator technology makes these partnerships fundamental to meeting this growing demand.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eActinium-225 Production:\u003c\/strong\u003e Partnerships focus on scaling up the production of key isotopes like Actinium-225, essential for advanced cancer treatments.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupply Chain Security:\u003c\/strong\u003e Collaborations aim to create a more robust and reliable supply chain for medical isotopes, mitigating shortages.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTechnology Advancement:\u003c\/strong\u003e Joint efforts drive innovation in accelerator technology, enhancing its application in radiopharmaceutical development and production.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIBA's Strategic Partnerships Drive Innovation and Market Leadership\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eIBA's Key Partnerships are crucial for its business model, spanning healthcare, research, and industrial sectors. These alliances ensure access to cutting-edge technology, facilitate market penetration, and drive innovation in particle therapy and industrial applications.\u003c\/p\u003e\n\u003cp\u003eIn 2024, IBA continued to strengthen its global network of hospital and research collaborations, exemplified by ongoing projects with leading oncology centers. These partnerships are vital for clinical validation and the advancement of proton therapy techniques.\u003c\/p\u003e\n\u003cp\u003eThe company also deepened ties with specialized component suppliers, securing critical elements for its accelerator systems, and expanded its industrial partnerships for sterilization technologies, with notable engagements in the medical device and food industries.\u003c\/p\u003e\n\u003cp\u003eFurthermore, collaborations in radiopharmaceuticals, particularly for isotopes like Actinium-225, are gaining momentum, addressing the growing demand in nuclear medicine. These strategic alliances underscore IBA's commitment to innovation and market leadership.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003ePartner Type\u003c\/th\u003e\n\u003cth\u003eExample Partner (2024\/Recent)\u003c\/th\u003e\n\u003cth\u003eStrategic Importance\u003c\/th\u003e\n\u003cth\u003eKey Activities\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals \u0026amp; Cancer Centers\u003c\/td\u003e\n\u003ctd\u003eHeidelberg University Hospital (DE), Apollo Hospitals (IN)\u003c\/td\u003e\n\u003ctd\u003eClinical validation, patient treatment, research\u003c\/td\u003e\n\u003ctd\u003eProton therapy system deployment, clinical trials, data collection\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eResearch Institutions \u0026amp; Universities\u003c\/td\u003e\n\u003ctd\u003eMajor European University (announced 2023)\u003c\/td\u003e\n\u003ctd\u003eTechnology advancement, novel applications\u003c\/td\u003e\n\u003ctd\u003eExploring advanced proton therapy, enhancing treatment precision\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTechnology \u0026amp; Component Suppliers\u003c\/td\u003e\n\u003ctd\u003eProviders of superconducting magnets \u0026amp; RF components\u003c\/td\u003e\n\u003ctd\u003eSupply chain reliability, high-quality components\u003c\/td\u003e\n\u003ctd\u003eSecuring essential parts, refining production methods\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIndustrial Clients \u0026amp; Service Providers\u003c\/td\u003e\n\u003ctd\u003eSteriLab, BENEBION\u003c\/td\u003e\n\u003ctd\u003eMarket expansion, service provision\u003c\/td\u003e\n\u003ctd\u003eDeploying sterilization tech, offering irradiation services\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRadiopharmaceutical Developers\u003c\/td\u003e\n\u003ctd\u003ePanTera (joint venture)\u003c\/td\u003e\n\u003ctd\u003eIsotope supply, nuclear medicine advancement\u003c\/td\u003e\n\u003ctd\u003eScaling Actinium-225 production, ensuring supply chain security\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA structured framework for outlining a business's core components, including customer segments, value propositions, channels, and revenue streams.\u003c\/p\u003e\n\u003cp\u003eIt provides a visual map of how a company creates, delivers, and captures value, aiding in strategic planning and innovation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eThe IBA Business Model Canvas helps alleviate the pain of unclear strategy by providing a structured, visual framework to map out all key business elements, ensuring no critical aspect is overlooked.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIBA's key activities heavily revolve around continuous research and development, a crucial element for maintaining its leadership in particle accelerator and proton therapy technology.  This ongoing investment fuels advancements in their core systems and the creation of innovative solutions for dosimetry and sterilization.\u003c\/p\u003e\n\u003cp\u003eIn 2024, IBA continued to prioritize innovation, launching new quality assurance solutions designed to enhance the precision and safety of radiation treatments.  They also made strides in radiochemistry, expanding their capabilities in producing essential isotopes for medical imaging and therapy.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManufacturing and Assembly\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIBA's core strength lies in the manufacturing and assembly of highly complex particle accelerators, proton therapy systems, and associated equipment. This intricate process demands specialized engineering talent and unwavering precision to ensure the reliability and efficacy of their advanced medical and industrial solutions.\u003c\/p\u003e\n\u003cp\u003eIn 2024, IBA continued to emphasize its manufacturing capabilities, with a significant portion of its revenue derived from the delivery of these sophisticated systems. The company's commitment to quality control is paramount, as evidenced by their adherence to rigorous international standards, which is crucial for the safety and performance of their products in critical healthcare applications.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInstallation and Commissioning\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eInstallation and commissioning of proton therapy centers and industrial sterilization facilities are highly complex, requiring meticulous project management and on-site engineering. These phases ensure systems are fully operational and compliant with stringent regulatory standards. IBA manages these critical deployments across the globe.\u003c\/p\u003e\n\u003cp\u003eIn 2024, IBA continued its track record of successful installations. For instance, the company announced the completion of commissioning for a new proton therapy center in Europe, a significant milestone that involved extensive calibration and testing of the cyclotron and beamlines. This process typically takes several months and involves a dedicated team of specialized engineers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSales, Marketing, and Distribution\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eIBA's sales, marketing, and distribution are geared towards reaching a global clientele, encompassing healthcare providers like hospitals and cancer centers, alongside industrial users.  Their strategy involves a direct sales force, active participation in key industry events, and targeted communications emphasizing the accuracy and advantages of their technological solutions.\u003c\/p\u003e\n\u003cp\u003eThe company actively seeks to broaden its international presence and capture a larger share of the market.  For instance, in 2024, IBA reported a significant increase in its order backlog, signaling strong demand for its proton therapy and particle accelerator systems across various regions.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eGlobal Reach:\u003c\/strong\u003e Targeting hospitals, cancer centers, and industrial clients worldwide.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSales Channels:\u003c\/strong\u003e Utilizing direct sales teams and industry conference participation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMarketing Focus:\u003c\/strong\u003e Highlighting technological benefits and precision.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGrowth Objective:\u003c\/strong\u003e Expanding global footprint and market share.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAfter-Sales Service and Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eIBA's commitment to comprehensive after-sales service, encompassing maintenance and technical support, is vital for the sustained operational efficiency of its installed systems. This dedication ensures maximum uptime and system longevity for clients.\u003c\/p\u003e\n\u003cp\u003eKey activities include proactive preventative maintenance schedules, advanced remote diagnostics capabilities, and responsive on-site repair services. These offerings not only solidify customer loyalty but also create a significant stream of recurring service revenue for IBA.\u003c\/p\u003e\n\u003cp\u003eThe importance of these services is underscored by financial performance. For instance, IBA reported robust growth in its services revenue during 2024, reflecting the increasing demand and value placed on its post-installation support.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003ePreventative Maintenance:\u003c\/strong\u003e Scheduled checks to avoid unexpected downtime.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRemote Diagnostics:\u003c\/strong\u003e Utilizing technology to identify and resolve issues remotely.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOn-Site Repairs:\u003c\/strong\u003e Prompt and efficient resolution of problems directly at the customer's location.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCustomer Relationship Management:\u003c\/strong\u003e Building long-term partnerships through reliable support.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAccelerating Innovation: Medical Tech \u0026amp; 2024 Advancements\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eIBA's key activities are centered on innovation and manufacturing. They focus on research and development for particle accelerators and proton therapy, alongside the production of dosimetry and sterilization solutions.  In 2024, this included launching new quality assurance tools and expanding radiochemistry capabilities for medical isotopes.\u003c\/p\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eDelivered as Displayed\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe IBA Business Model Canvas preview you are viewing is the actual document you will receive upon purchase. This means the structure, content, and formatting are identical to the final deliverable, ensuring no surprises. You can confidently assess its quality and relevance knowing that the complete, ready-to-use file will be yours instantly after completing your order.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":55674807288185,"sku":"iba-worldwide-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/iba-worldwide-business-model-canvas.png?v=1755795979","url":"https:\/\/portersfiveforce.com\/products\/iba-worldwide-business-model-canvas","provider":"Porter's Five Forces","version":"1.0","type":"link"}